Who Paid My Doc
Lamotrigine
Drug Neurology
NDC 55111-226-05
General payments
$123,500
Research payments
$133,000
Through program year 2024, $123,500 in general payments and $133,000 in research payments were reported against Lamotrigine (Neurology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $133,000 | 2 |
| 2022 | General | $66,500 | 1 |
| 2021 | General | $57,000 | 1 |
Breakdown
Prescribed to Medicare patients
Part D · data year 2024Part D claims
3,766,590
Drug cost
$141,020,640
| Part D drug | Name match | Relative to the largest | Prescribers | Claims | Drug cost |
|---|---|---|---|---|---|
| Lamotrigine | Same name | 76,777 | 3,623,880 | $50,982,255 | |
| Lamictal Lamotrigine | Same name | 1,325 | 27,972 | $34,526,294 | |
| Lamictal Xr Lamotrigine | Same name | 469 | 9,995 | $26,640,337 | |
| Lamotrigine Er Lamotrigine | Same name | 4,008 | 94,131 | $24,498,215 | |
| Lamotrigine Odt Lamotrigine | Same name | 552 | 9,280 | $3,175,456 | |
| Lamictal Odt Lamotrigine | Same name | 63 | 940 | $1,192,113 | |
| Subvenite Lamotrigine | Same name | 18 | 392 | $5,969 |
Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.
Largest prescribers
First 5 of 472 by claims · 2024Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.
| Prescriber | Specialty | State | Claims | Drug cost | Related payments |
|---|---|---|---|---|---|
| Robert Morton | Psychiatry | OK | 3,616 | $58,135 | None on record |
| Vivian Acevedo | Psychiatry | PR | 1,941 | $12,007 | None on record |
| Francisco Parra | Psychiatry | PR | 1,699 | $10,466 | None on record |
| Eric Geller | Neurology | NJ | 1,545 | $477,821 | None on record |
| Robert Pearlstein | Internal Medicine | PA | 1,508 | $18,337 | None on record |
"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.
See more in the dashboard: 25 with a free account, all 472 with PatronRecords
2 general · 2 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.